An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
QIAGEN N.V. (QGEN) announced plans to release results for the first quarter 2024. The press release date is set for Monday, April 29, shortly after 22:05 Frankfurt time, with a conference call scheduled for Tuesday, April 30. Investors can join the call via phone or webcast.
Positive
None.
Negative
None.
Venlo, The Netherlands, April 09, 2024 (GLOBE NEWSWIRE) -- QIAGEN N.V. (NYSE: QGEN) (Frankfurt Stock Exchange: QIA) announced plans to release results for the first quarter 2024.
Press release date / time: Monday, April 29, shortly after 22:05Frankfurt time / 21:05 London time / 16:05 New York time.
Conference call date / time: Tuesday, April 30, at15:00 Frankfurt time / 14:00 London time / 09:00 New York time.
Three options for joining the conference call
Register for call back connection - Click here: Connect me Service is available 15 minutes before the call starts
Dial-in by phone U.S.: +1 646 828 8193 UK: +44 (0)330 165 3655 GER: +49 (0)69 6610 2492 Conference ID: 2903795 To avoid waiting time, please join the event conference 5-10 minutes prior to the start time.
About QIAGEN QIAGEN N.V., a Netherlands-based holding company, is the leading global provider of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. Our sample technologies isolate and process DNA, RNA and proteins from blood, tissue and other materials. Assay technologies make these biomolecules visible and ready for analysis. Bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. Automation solutions tie these together in seamless and cost-effective workflows. QIAGEN provides solutions to more than 500,000 customers around the world in Molecular Diagnostics (human healthcare) and Life Sciences (academia, pharma R&D and industrial applications, primarily forensics). As of December 31, 2023, QIAGEN employed approximately 6,000 people in over 35 locations worldwide.
QIAGEN N.V. plans to release results for the first quarter of 2024 on Monday, April 29, shortly after 22:05 Frankfurt time.
Investors can join the conference call for QIAGEN N.V. on Tuesday, April 30, at 15:00 Frankfurt time by dialing in using the provided phone numbers or accessing the webcast.
The conference call for QIAGEN N.V. is scheduled for Tuesday, April 30, at 15:00 Frankfurt time, with dial-in numbers for the U.S., UK, and Germany provided along with the conference ID.
qiagen is the leading global provider of sample to insight solutions to transform biological materials into valuable molecular insights. qiagen sample technologies isolate and process dna, rna and proteins from blood, tissue and other materials. assay technologies make these biomolecules visible and ready for analysis. bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. automation solutions tie these together in seamless and cost-effective molecular testing workflows. qiagen provides these workflows to more than 500,000 customers around the world in molecular diagnostics (human healthcare), applied testing (forensics, veterinary testing and food safety), pharma (pharmaceutical and biotechnology companies) and academia (life sciences research). as of june 30, 2015, qiagen employed approximately 4,400 people in over 35 locations worldwide. further information can be found at http://www.qiagen.com.
